Novadaq Corp. Completes Purchase of Xillix Technologies' Portfolio Of Fluorescence Endoscopy Patents

TORONTO, May 3 /PRNewswire-FirstCall/ - Novadaq® Technologies Inc. (TSX: NDQ - News), a developer of real-time medical imaging systems and image guided therapies for the operating room, announced today that it has completed the purchase of all intellectual property, certain capital assets and inventory from Xillix Technologies Corp. (Richmond, British Columbia) including, an extensive auto-fluorescence and multi-modal imaging portfolio of 31 issued patents and multiple pending applications in the United States, Japan and Europe and licensed rights to certain innovative fluorescence imaging technologies.